Does sodium nitroprusside decrease the incidence of atrial fibrillation after myocardial revascularization? A pilot study

Circulation

Volumn 118, Issue 5, 2008, Pages 476-481

  Cavolli, Raif ^a,c   Kaya, Kaan ^a   Aslan, Alp ^a   Emiroglu, Ozan ^a   Erturk, Sebnem ^a   Korkmaz, Ozge ^a   Oguz, Mehmet ^a   Tasoz, Refik ^b   Ozyurda, Umit ^b  

^a Kavaklidere Umut Hospital   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Department of Cardiovascular Surgery   (Turkey)

Author keywords

Atrial fibrillation; Myocardial revascularization; Sodium nitroprusside

Indexed keywords

NITROPRUSSIDE SODIUM; C REACTIVE PROTEIN; NITRIC OXIDE DONOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TELEMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; INCIDENCE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PILOT STUDY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NITRIC OXIDE DONORS; NITROPRUSSIDE; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TREATMENT OUTCOME;

EID: 49649115591     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.719377     Document Type: Article

References (29)

1. Zaman AG, Archbold RA, Helft G, Paul EA, Curzen NP, Mills PG. Atrial fibrillation after coronary bypass surgery: a model for preoperative risk stratification. Circulation. 2000;101:1403-1408.
2. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, Van der Vliet M, Collins JJ Jr, Cohn LH, Burstin HR. Predictors of atrial fibrillation after coronary artery bypass surgery: current trends and impact on hospital resources. Circulation. 1996;94:390-397.
3. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56:539-549.
4. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT; for the Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291:1720-1729.
5. Hogue CW Jr, Hyder ML. Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment. Ann Thorac Surg. 2000;69:300-306.
6. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135:1061-1073.
7. Hogue CW Jr, Creswell LL, Gutterman DD, Fleisher LA; American College of Chest Physicians. Epidemiology, mechanisms, risk: American College of Chest Physicians guidelines for prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005; 128:9-16.
8. Allesie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ. Rosen MR, Schwanz PJ, Spooner PM, Van Wagoner DR, Waldo AL. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103:769-777
9. Aviles RJ, Martin DO, Apperson-Henson C, Houghtaling PL. Rautaharju P. Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM. Lauer MS, Chung MK. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006-3010.
10. Daoud EG, Strickberger SA, Man KC. Goyal L, Deeb GM, Boiling SF, Pagani FD, Bitar C, Meissnere MD, Morady F. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med. 1997;337:1785-1791.
11. Redle JD, Khurana S, Marzan R, McCullough PA, Stewart JR, Westveer DC, O'Neill WW, Basset JS, Tepe NA, Frumin HI. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J. 1999; 138:144-150.
12. Budeus M, Hennersdorf M, Perings S, Röhlen S. Schnitzler S, Felix O. Reimert K, Feindt P, Gams E, Lehmann N, Wieneke H, Sack S. Erbel R, Perings C. Amiodarone prophylaxis for atrial fibrillation of high risk patients after coronary artery bypass grafting: a prospective, doubleblinded, placebo-controlled, randomized study. Eur Heart J. 2006;27: 1584-1591.
13. Treggiari-Venzi MM. Waeber JL. Perneger TV. Suter PM. Adamec R, Romand JA. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth. 2000;85:690-695.
14. Gomes JA, Ip J, Santoni-Rugiu F, Mehta D, Ergin A, Lansman P, Pe E. Newhouse TT, Chao S. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1999;34:334-339.
15. Solomon A, Berger A. Triverdi K. Hannan R, Katz N. The combination of propranolol and magnesium does not prevent postoperative atrial fibrillation. Ann Thorac Surg. 2000;69:126-129.
16. Tokmakoglu H. Kandemir O, Gunaydin S, Catav Z, Yorgancioglu C. Zorlutuna Y. Amiodarone versus digoxin and metoprolol combination for prevention of postcoronary bypass atrial fibrillation. Eur J Cardiothorac Surg. 2002;21:401-405.
17. Aerra V, Kuduvalli M, Moloto AN, Srinivasan AK, Grayson AD, Fabri BM, Oo AY. Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: a propensity-matched analysis. J Cardiothoracic Surgery. 2006;1:6.
18. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, Di Scascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006;114:1455-1461.
19. Prasongsukarn K, Abel JG, Jameison E, Jamieson EWR. Cheung A. Russel JA, Walley KR, Lichtenstein SV. The effects of steroids on occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg. 2005;130:93-98.
20. Debrunner M, Naegeli B, Genoni M, Turina M, Bertel O. Prevention of atrial fibrillation after cardiac valvular surgery by epicardial, biatrial synchronous pacing. Eur J Cardiothorac Surg. 2004;25:16-20.
21. Massoudy P, Zahler S, Barankay A, Becker BF, Richter JA, Meisner H. Sodium nitroprusside during coronary artery bypass grafting: evidence for an antiinflammatory action. Ann Thorac Surg. 1999;67:1059-1064.
22. Kaya K, Oguz M, Akar RA, Durdu S, Aslan A, Erturk S, Tasoz R. Ozyurda U. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg. 2007;31:290-297.
23. Cakir O, Oruc A, Eren S, Buyukbayram H, Erdinc L, Eren N. Does sodium nitroprusside reduce lung injury under cardiopulmonary bypass? Eur J Cardiothorac Surg. 2003;23:1040-1045.
24. He GW. Endothelial function related to vascular tone in cardiac surgery. Heart Lung Circ. 2005;14:13-18.
25. Boos CJ. Anderson RA, Lip GYH. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006;27:136-149.
26. Rubart M, Zipes DP. No hope for patients with atrial fibrillation. Circulation. 2002;106:2764-2766.
27. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, Wildevuur CR, Eijsman L, Trouwborst A, Hack CE. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;36: 3542-3548.
28. Yamamoto T, Bing RJ. Nitric oxide donors. Proc Soc Exp Biol Med. 2000;225:200-206.
29. Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res. 2003;93:388-398.